PYSZCZYMUKA GREG
CIK: 0001952920•Chief Commercial Officer
OfficerDirector
Primary company: AYTU BIOPHARMA, INC (AYTU)
PYSZCZYMUKA GREG is a corporate insider (Chief Commercial Officer) at AYTU BIOPHARMA, INC (AYTU) filing SEC Form 4 transactions. 28 transactions across 2 companies, totaling $46,908 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 20,000 | - | - | 56,102 | 7/28/2026 Filed: 7/28/2026 | Filing → | |
Evoke Pharma Inc EVOK | Disposition | 1,155 | - | - | 0 | 12/17/2025 Filed: 12/17/2025 | Filing → |
Evoke Pharma Inc EVOK | Disposition | 5,833 | - | - | 0 | 12/17/2025 Filed: 12/17/2025 | Filing → |
| Award | 12,500 | - | - | 36,102 | 10/3/2025 Filed: 10/7/2025 | Filing → | |
Evoke Pharma Inc EVOK | Award | 1,155 | - | - | 6,988 | 5/21/2025 Filed: 5/22/2025 | Filing → |
| Exercise | 209 | - | - | 0 | 3/31/2025 Filed: 3/31/2025 | Filing → | |
| Exercise | 209 | - | - | 23,602 | 3/31/2025 Filed: 3/31/2025 | Filing → | |
Evoke Pharma Inc EVOK | Award | 5,833 | $5.26 | $31K | 5,833 | 2/20/2025 Filed: 2/24/2025 | Filing → |
| Exercise | 208 | - | - | 209 | 12/31/2024 Filed: 1/2/2025 | Filing → | |
| Exercise | 208 | - | - | 23,393 | 12/31/2024 Filed: 1/2/2025 | Filing → | |
| Award | 7,000 | - | - | 7,000 | 11/6/2024 Filed: 11/8/2024 | Filing → | |
| Exercise | 209 | - | - | 417 | 9/30/2024 Filed: 10/2/2024 | Filing → | |
| Exercise | 209 | - | - | 23,185 | 9/30/2024 Filed: 10/2/2024 | Filing → | |
| Exercise | 208 | - | - | 626 | 6/30/2024 Filed: 7/2/2024 | Filing → | |
| Exercise | 208 | - | - | 22,976 | 6/30/2024 Filed: 7/2/2024 | Filing → | |
| Exercise | 208 | - | - | 834 | 3/31/2024 Filed: 4/2/2024 | Filing → | |
| Exercise | 208 | - | - | 22,768 | 3/31/2024 Filed: 4/2/2024 | Filing → | |
| Exercise | 209 | - | - | 1,042 | 12/31/2023 Filed: 1/2/2024 | Filing → | |
| Exercise | 209 | - | - | 22,560 | 12/31/2023 Filed: 1/2/2024 | Filing → | |
| Exercise | 208 | $0.00 | $0 | 1,251 | 9/30/2023 Filed: 10/3/2023 | Filing → |
Type
Award
Shares
20,000
Price
-
Value
-
Evoke Pharma Inc
EVOK
Type
Disposition
Shares
1,155
Price
-
Value
-
Evoke Pharma Inc
EVOK
Type
Disposition
Shares
5,833
Price
-
Value
-
Type
Award
Shares
12,500
Price
-
Value
-
Evoke Pharma Inc
EVOK
Type
Award
Shares
1,155
Price
-
Value
-
Type
Exercise
Shares
209
Price
-
Value
-
Type
Exercise
Shares
209
Price
-
Value
-
Evoke Pharma Inc
EVOK
Type
Award
Shares
5,833
Price
$5.26
Value
$31K
Type
Exercise
Shares
208
Price
-
Value
-
Type
Exercise
Shares
208
Price
-
Value
-
Type
Award
Shares
7,000
Price
-
Value
-
Type
Exercise
Shares
209
Price
-
Value
-
Type
Exercise
Shares
209
Price
-
Value
-
Type
Exercise
Shares
208
Price
-
Value
-
Type
Exercise
Shares
208
Price
-
Value
-
Type
Exercise
Shares
208
Price
-
Value
-
Type
Exercise
Shares
208
Price
-
Value
-
Type
Exercise
Shares
209
Price
-
Value
-
Type
Exercise
Shares
209
Price
-
Value
-
Type
Exercise
Shares
208
Price
$0.00
Value
$0
AI Agent
Try asking...